Annie Lamont is a Co-Founder and Managing Partner of Oak HC/FT where she focuses on venture and growth opportunities in Healthcare and FinTech.
Ms. Lamont currently serves on the Boards of Advise Health Holdings, Brightline, CareBridge, Clearco, Main Street Health, Modern Age, OncoHealth, Quartet, Truepill, Vesta Health and VillageMD. She is also a Board Observer at Notable. Ms. Lamont is also actively involved with Blend (NYSE: BLND), Devoted Health, Inscripta, Komodo Health, Precision Medicine Group, Rubicon Founders and TurningPoint Healthcare Solutions.
Ms. Lamont has been featured on the Forbes Midas List, Modern Healthcare's 100 Most Influential People in Healthcare list, Institutional Investor’s FinTech Finance 40 list, and the Top 100 Venture Capitalist rankings published by CB Insights and The New York Times. She was the first recipient of the National Venture Capital Association’s award for Excellence in Healthcare Innovation. Ms. Lamont was also honored with the Healthcare Private Equity Association’s 2017 Russell L. Carson Award for lifetime achievement in healthcare investing. Ms. Lamont served as a core participant of the Health and Human Services Deputy Secretary’s Innovation and Investment Summit (DSIIS). Ms. Lamont also served on the Stanford University Board of Trustees and the Executive Board of the National Venture Capital Association.
She received a Bachelor of Arts degree from Stanford University.